Safi Morteza, Namazi Mohammad Hasan, Fooladi Esfandiar, Vakili Hossein, Parsa Saeed Alipour, Khaheshi Isa, Abbasi Mohammad Amin, Movahed Mohammad Reza
Cardiovascular Research Center, Modarres hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):441-443. doi: 10.1016/j.carrev.2016.05.011. Epub 2016 Jun 17.
The aim of this study was to investigate the efficacy and safety of intracoronary (IC) sodium nitroprusside infusion in comparison to IC adenosine for fractional flow reserve (FFR) measurement in moderately diseased coronary artery lesions for functional assessment.
During a nine month period, a consecutive of 98 patients with suspected or known coronary artery disease with moderate stenosis found during angiography (40% to 70% stenosis), were enrolled in this study. Hyperemia was induced by bolus doses of IC adenosine followed by sodium nitroprusside for FFR measurement.
Both IC adenosine and IC sodium nitroprusside induced similar and significant reduction in FFR. There was no statistically difference in FFR values between adenosine vs sodium nitroprusside infusions (mean FFR 84.3±6.3 vs 85.7±6.2, p=0.1) respectively. Furthermore, comparing different FFR cut-off points between the groups (FFR<0.75, 0.75-0.8 and >0.8) showed no significant differences (p value=0.7).
An IC bolus of sodium nitroprusside (0.6μg/kg) infusion induces a similar degree of hyperemia to IC bolus of 100-300μg of adenosine. Therefore, IC sodium nitroprusside could be considered as an alternative drug to adenosine for FFR measurement with lower side effect profile.
本研究旨在比较冠状动脉内(IC)输注硝普钠与IC输注腺苷用于中度病变冠状动脉病变功能评估中血流储备分数(FFR)测量的疗效和安全性。
在九个月的时间里,连续纳入98例疑似或已知患有冠状动脉疾病且在血管造影中发现中度狭窄(40%至70%狭窄)的患者。通过静脉推注IC腺苷诱导充血,随后静脉推注硝普钠进行FFR测量。
IC腺苷和IC硝普钠均导致FFR出现相似且显著的降低。腺苷输注与硝普钠输注之间的FFR值无统计学差异(平均FFR分别为84.3±6.3和85.7±6.2,p = 0.1)。此外,比较两组之间不同的FFR切点(FFR<0.75、0.75 - 0.8和>0.8),未发现显著差异(p值 = 0.7)。
静脉推注IC硝普钠(0.6μg/kg)输注诱导的充血程度与静脉推注100 - 300μg腺苷相似。因此,IC硝普钠可被视为用于FFR测量的腺苷替代药物,且副作用较小。